Etiology
The etiologies of hypocalcemia may be classified on the basis of parathyroid hormone (PTH) levels, or, alternatively, physiologically (e.g., insufficient entry into or increased loss of calcium from the circulation). Etiologies may be interrelated.
Classification based on PTH levels
Hypocalcemia with inappropriately low serum PTH
Destruction of parathyroid glands
Surgery, autoimmune, radiation, infiltration (iron, copper, tumor)
Developmental parathyroid disorders
Isolated hypoparathyroidism
Autosomal recessive, autosomal dominant, or X-linked
Syndromes of hypoparathyroidism associated with complex developmental anomalies (e.g., DiGeorge sequence)
Reduced PTH secretion/function
Constitutively activating calcium sensing receptor (CaSR) mutations/autoimmune activation of the CaSR
Hypomagnesemia
Hungry bone disease following parathyroidectomy.
Hypocalcemia with secondary hyperparathyroidism
Vitamin D deficiency
Inadequate ultraviolet B light exposure, poor diet, malabsorption
Chronic renal disease, enzyme-induced drug resistance to PTH
Pseudohypoparathyroidism
Hypomagnesemia
Resistance to vitamin D
Mutations in vitamin D receptor (mutations in 1-alpha hydroxylase enzyme).
Miscellaneous
Following drug treatment
Intravenous bisphosphonates (and other drugs that inhibit bone turnover) in untreated vitamin D deficiency
Gadolinium salts used in magnetic resonance imaging
Foscarnet
Osteoblastic metastases
Hyperphosphatemia
Severe illness
Acute pancreatitis
Acute rhabdomyolysis
Tumor lysis
Post massive transfusion.
Decreased entry of calcium into the circulation
Hypoparathyroidism is a well recognized cause of hypocalcemia. It is often caused by accidental removal of all the parathyroid glands during surgery or radiation-induced parathyroid destruction. Low levels of parathyroid hormone (PTH) secretion are sometimes congenital (as in DiGeorge syndrome and velocardiofacial syndrome); hypoparathyroidism may also be autosomal dominant (hypocalcemia with hypercalciuria) or autoimmune (occurring as an isolated entity or as part of polyglandular failure type 1, which is seen in association with adrenal insufficiency and mucocutaneous candidiasis).[7]
Repeated blood transfusions for chronic anemia, or defects of iron metabolism (e.g., hemochromatosis) or copper metabolism (e.g., Wilson disease), and less commonly a current malignancy, could suggest an infiltrative process in the parathyroid glands.[8][9]
Nutritional: vitamin D deficiency is the most common cause of hypocalcemia.[10][11] Circulating vitamin D levels may be reduced by lack of exposure to sunshine and reduced vitamin D intake, resulting in calcium malabsorption.[11]
Magnesium imbalance: the presence of hypomagnesemia can cause hypocalcemia by interfering with the secretion and action of PTH. Hypomagnesemia generally occurs as a primary disorder that is secondary to defects in intestinal absorption and renal absorption or as a secondary disorder due to nutritional deficiency, as seen in patients with chronic alcoholism.[12]
PTH resistance, or pseudohypoparathyroidism, encompasses a group of hereditary disorders that involve resistance to the effects of PTH (e.g., renal and bone unresponsiveness to PTH). In contrast to hypoparathyroidism, pseudohypoparathyroidism is characterized by high levels of PTH and phosphorus in conjunction with hypocalcemia.[13] Pseudohypoparathyroidism has other phenotypes such as Albright hereditary osteodystrophy (associated with short stature, round facies, short digits, and intellectual impairment) and pseudopseudohypoparathyroidism (a condition where the individual has the physical appearance associated with pseudohypoparathyroidism but has normal biochemistry).[14]
Increased loss of calcium from the circulation
The "hungry bone syndrome" refers to a state of severe hypocalcemia that can be seen after parathyroidectomy (or thyroidectomy).[15][16] Calcium is rapidly taken from the circulation and deposited in stores in the bones. In severe cases patients may develop cardiovascular collapse, arrhythmias, and hypotension unresponsive to fluids and vasopressors.
Acute pancreatitis can lead to hypocalcemia, which is associated with a poor prognosis.[17]
Extensive osteoblastic skeletal metastases, such as those that occur in breast or prostate cancer, can result in hypocalcemia.[18][19]
Hyperphosphatemia occurs after massive tissue breakdown in rhabdomyolysis, after accidental ingestion of phosphate-containing drugs, in tumor lysis syndrome, or in critically sick patients.[20][21][22] Phosphate binds to calcium, leading to acute hypocalcemia.
Chelating agents, such as citrate, EDTA (ethylenediaminetetraacetic acid), lactate, and foscarnet, can increase loss of calcium from the circulation.
Drug-induced hypocalcemia and other causes
Hypocalcemia can be induced by certain drugs (particularly if there is coexisting vitamin D deficiency): these include bisphosphonates, particularly when given intravenously; denosumab; chemotherapies; glucocorticoids; anticonvulsants; and chelating agents such as citrate, EDTA (ethylenediaminetetraacetic acid), lactate, and foscarnet.[23][24] Cinacalcet, which is usually given to patients with renal failure to inhibit PTH release, can also cause hypocalcemia.[25] Proton-pump inhibitors may cause hypomagnesemia, which in turn causes hypocalcemia.
Critically ill patients may have transient hypocalcemia, as seen in conditions such as sepsis or extensive burns, or after multiple blood transfusions. Hypocalcemia is extremely common in patients admitted to the hospital (occurring in up to 88% of patients admitted to medical, surgical, trauma, neurosurgical, burn, respiratory, and coronary intensive care units); the likelihood of hypocalcemia occurring correlates with severity of illness, but not with a specific illness per se.[26][27] The low serum calcium levels seen in these patients can be caused by the citrate content of transfused blood, receiving large quantities of fluids, and/or hypoalbuminemia. Any condition that lowers plasma protein levels can also cause hypocalcemia. For more information on sepsis, see Sepsis in adults and Sepsis in children.
Use of gadolinium-based magnetic resonance imaging contrast agents, such as gadodiamide and gadoversetamide, can interfere with the colorimetric assay of serum calcium levels leading to falsely lowered results.[28]
Use of this content is subject to our disclaimer